[{"id":"63d174f5-1045-41f8-a030-f399abb4d1dd","acronym":"NCI-2016-00073","url":"https://clinicaltrials.gov/study/NCT02697344","created_at":"2021-01-18T13:10:03.223Z","updated_at":"2024-07-02T16:35:25.022Z","phase":"Phase 1","brief_title":"Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma","source_id_and_acronym":"NCT02697344 - NCI-2016-00073","lead_sponsor":"Mayo Clinic","biomarkers":" BCL2 • CRBN • MAPK1","pipe":" | ","alterations":" BCL2 expression • CRBN expression","tags":["BCL2 • CRBN • MAPK1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BCL2 expression • CRBN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lenalidomide • R-(-)-gossypol (AT 101)"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 04/14/2016","start_date":" 04/14/2016","primary_txt":" Primary completion: 10/26/2018","primary_completion_date":" 10/26/2018","study_txt":" Completion: 12/20/2023","study_completion_date":" 12/20/2023","last_update_posted":"2023-12-28"},{"id":"7b2c5466-64ab-4565-8ea2-f8b1f2dcb850","acronym":"","url":"https://clinicaltrials.gov/study/NCT01737177","created_at":"2021-01-18T07:35:56.763Z","updated_at":"2024-07-02T16:37:13.170Z","phase":"Phase 2","brief_title":"Bendamustine/Lenalidomide/Rituximab: Combination as a Second-Line Therapy for 1st Relapsed-Refractory MCL","source_id_and_acronym":"NCT01737177","lead_sponsor":"Fondazione Italiana Linfomi ONLUS","biomarkers":" CRBN","pipe":" | ","alterations":" CRBN expression","tags":["CRBN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CRBN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Rituxan (rituximab) • lenalidomide • bendamustine"],"overall_status":"Completed","enrollment":" Enrollment 42","initiation":"Initiation: 07/31/2012","start_date":" 07/31/2012","primary_txt":" Primary completion: 07/01/2014","primary_completion_date":" 07/01/2014","study_txt":" Completion: 02/02/2017","study_completion_date":" 02/02/2017","last_update_posted":"2018-03-09"}]